Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese Scientists Collaborate On New AIDS Vaccine

This article was originally published in PharmAsia News

Executive Summary

Hong Kong and Mainland China scientists are concentrating on three particular variants of HIV common among people in West China, Hong Kong and Taiwan to develop an AIDS vaccine. The scientists are basing their work on a collaborative effort by Chinese and U.S. researchers who designed a vaccine based on two of the HIV variants. The director of the new AIDS Institute in Hong Kong said the hope is the designed vaccine treating the two variants spread among drug users also will work on the third variant, spread through sex. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066695

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel